Intensity, duration of drug shortages are spiking, FDA says
(By Alia Paavola for Becker’s Hospital Review) The FDA is not only seeing an increased incidence of drug shortages, there’s
Read More
Month: November 2018
‘A loss for the rest of us’: An FDA approval is a boon for a drug maker, but could come at a major cost for patients
(By Meghana Keshavan for STAT) Vickie Moored can walk again. Her words don’t slur, her vision isn’t blurred, and she
Read MoreRecognizing Suicide’s Warning Signs Could Save Lives
(By Christine Vestal for Stateline, an initiative of The Pew Charitable Trusts) PORTLAND — For Portland resident Stephen Canova, thoughts
Read MoreThe long-delayed 340B final rule is out
The rule for the 340B drug discount program, which would set price ceilings and monetary penalties, will begin of next
Read MoreIs Trump Pushing Health Insurance Innovation Or An ACA Rollback?
(By Julie Appleby for Kaiser Health News) On his first day in office, as part of his mission to dismantle
Read MoreGerms on a journey: How infectious diseases become unwelcome companions during air travel
(By Alex Hogan for STAT) When Emirates Flight EK203 landed at New York’s John F. Kennedy Airport last September, it
Read MoreTrump won’t leave patients with pre-existing conditions out in the cold, CMS chief says
(By Kelly Gooch for Becker’s Hospital Review) CMS Administrator Seema Verma said the Trump administration plans to protect health insurance
Read MoreCVS closes $70B Aetna deal to ‘transform the way healthcare is delivered’
(By Morgan Haefner for Becker’s Hospital Review) CVS Health completed its $70 billion acquisition of Aetna Nov. 28, in a
Read MoreMedicare Part D costs and deductibles for 2019
Do you know what is covered under Medicare Part D? Did you know that private companies that offer Part D
Read MoreDemocrats Taking Key Leadership Jobs Have Pocketed Millions From Pharma
(By Emmarie Huetteman for Kaiser Health News) Three of the lawmakers who will lead the House next year as Congress
Read More